期刊文献+

连续性肾脏替代治疗对严重脓毒症患者外周血T淋巴细胞免疫功能的影响 被引量:10

Effect of CRRT on immune function of peripheral blood T lymphocytes-mediated in patients with severe sepsis
下载PDF
导出
摘要 目的:探讨连续性肾脏替代治疗(CRRT)对严重脓毒症患者外周血T淋巴细胞免疫功能的影响。方法:将85例严重脓毒症患者随机分成两组,对照组给予常规治疗,观察组在常规治疗基础上加CRRT治疗,观察两组疗效;治疗5d后,体外分离、培养外周血T淋巴细胞,采用MTT法检测治疗前后外周血T淋巴细胞增殖反应;采用ELISA法检测培养上清IL-2的分泌量。结果:观察组治愈率为81.4%,明显高于对照组59.5%(P<0.05);观察组较对照组T细胞增殖反应及IL-2表达量升高(P<0.05)。结论:CRRT治疗脓毒症疗效明显,并能有效改善严重脓毒症患者T淋巴细胞免疫功能。 Objective To investigate the effect of CRRT on immune function of peripheral blood T lymph0cytes in patients with severe sepsis. Methods Eighty-five patients with severe sepsis were randomly divided into two groups: the CRRT treatment group and the control group, the patients in the CRRT group were received routine therapy and CRRT. Peripheral blood T lymphoeytes were cultured and incubated with 20 μg/mL of phytohemagglutin (PHA) at 37℃ under 5% CO2. Cell proliferation was assessed by tetrazolium blue (MTT) assay 68 hours after PHA incubation. The IL-2 concentration in the supernatant fluid was determined by enzyme linked immunosorbent assay(ELISA). Results The recovery rate of patients in the CRRT group was 81.4% which was higher than 59.5% in the control group. Proliferation activity of peripheral blood T lymphocytes and IL-2 level in CRRT group were significantly higher than those in the control group. Conclusion CRRT can improve immune function of T lymphocyte in patients with severe sepsis, contributing to the treatment effect of patients with severe sepsis.
出处 《实用医学杂志》 CAS 北大核心 2012年第22期3745-3747,共3页 The Journal of Practical Medicine
基金 温州市科技局资助项目(编号:Y20120108)
关键词 脓毒症 连续性肾脏替代治疗 T淋巴细胞免疫功能 Sepsis Continue renal replacement therapy Immune function ofT lymphoeytes
  • 相关文献

参考文献8

二级参考文献60

共引文献310

同被引文献96

  • 1彭侃夫,吴雄飞,赵洪雯,王军霞,吴亿,王殿珍,赵笑兰.连续性血液净化治疗多器官功能衰竭对Th1/Th2影响的临床研究[J].第三军医大学学报,2005,27(18):1877-1879. 被引量:14
  • 2Liao MM, Lezotte D, Lowenstein SR, et al. Sensitivity of systemic inflammatory response syndrome for critical illness among ED patients[J]. Am J Emerg Med, 2014, 32(11): 1319-1325.
  • 3Schneider AG, Bagshaw SM. Effects of renal replacement therapy on renal recovery after acute kidney injury [J]. Nephron Clin Pract, 2014, 127(1/4): 35--41.
  • 4Chua HR, Baldwin I, Bailey M, et al. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure[J]. J Crit Care, 2012, 27(6): 744, 747-715.
  • 5Davies GR, Mills GM, Lawrence M, et al. The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness[J]. PLoS One, 2014, 9(9): e108589.
  • 6Reichsoellner M, Raggam RB, Wagner J, et al. Clinical evaluation of muhiple inflammation biomarkers for diagnosis and prognosis for patients with systemic inflammatory response syndrome[J]. J Clin Microbiol, 2014, 52(11): 4063-4066.
  • 7Jit M, Henderson B, Stevens M, et al. TNF-alpha neutralization in cytokine-driven diseases: a mathematicalmodel to account for therapeutic success in rheumatoid arthritis but therapeutic failure in systemic inflammatory response syndrome[J]. Rheumatology (Oxford), 2005, 44(3): 323-331.
  • 8Oda S, Hirasawa H, Shiga H, et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis[J]. Cytokine, 2005, 29(4): 169-175.
  • 9Bosmann M, Ward PA. Therapeutic potential of targeting IL-17 and IL-23 in sepsis[J]. Clin Transl Med, 2012, 1(1): 4-5.
  • 10Honore PM, Jacobs R, Joannes Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review[J]. Asaio J, 2013, 59(2): 99-106.

引证文献10

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部